Acellular dermal matrices are used as substitutes for autografts in skin grafting procedures. They are manufactured from human or animal tissues by removing cellular components and excess extracellular matrix to reduce immunogenicity. Acellular dermal matrices provide wound stability, revascularization, and adequate blood supply for skin grafts and lead to less complications compared to autografts. The growing prevalence of burns and skin ulcers along with rising plastic and reconstructive surgeries are driving the demand for acellular dermal matrices.
The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Product innovation is one of the key trends witnessed in the U.S. acellular dermal matrices market. Companies are developing advanced products with improved performance and ease of use. For instance, in 2020, MiMedx Group launched AmnioFix® Nerve Wrap, a minimally manipulated acellular nerve wrap intended for peripheral nerve repair that provides neuroconductive pathways for nerve regeneration. Similarly, in 2019, Stratatech Corporation launched a family of HydroToneTM Acellular Dermal Matrix products for wound repair and reconstruction. HydroToneTM ADM is derived from human tissues and hydrated to enhance performance. Such innovative new product launches are expected to drive market growth over the forecast period.
Segment Analysis
The U.S. acellular dermal matrices market is dominated by the tissue processing sub-segment. This is because tissue processing helps in preparing acellular dermal matrices from donor skin tissue which is then used for various applications such as breast reconstruction and dural repair. The tissue is processed to remove cellular components while maintaining the structural proteins to mimic natural dermal tissue.
Key Takeaways
The Global U.S. Acellular Dermal Matrices Market Size is expected to witness high growth. The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030.
Regional analysis related content comprises The western United States region currently dominates the market due to high incidence of breast cancer and increasing breast reconstruction procedures being performed in this region. Factors such as rising awareness about aesthetic procedures and availability of technologically advanced products are also supporting market growth.
Key players related content comprises Key players operating in the U.S. acellular dermal matrices market are Biomet, Inc., Wright Medical Technology, Inc., Smith & Nephew Plc, and Stryker. Biomet, Inc. offers various tissue processing services and acellular dermal matrices under its brands such as AlloDerm and DermaMatrix. Wright Medical Technology, Inc. provides acellular dermal matrices under the GraftJacket brand. Similarly, Smith & Nephew Plc offers Permacol brand of products. Stryker is another prominent player providing various tissue processing services and products for breast reconstruction applications.
Explore more information on this topic, Please visit -
https://www.insightprobing.com/u-s-acellular-dermal-matrices-market-share-and-demand-analysis/
Explore more trending article on this topic -
https://diveintoinsights.blogspot.com/2023/11/skin-substitution-products-is-largest.html
Comments
Post a Comment